top of page
Our Pipeline
Program
Indication
MoA Highlight
Stage
CG-KR-301
Polycystic Ovary Syndrome
AKR1C3 Inhibitor
Lead optimisation (in-vivo PK)
CG-ALZ-01
Alzheimer’s Disease
Increase Phagocytosis of Amyloid by Brain Microglia activation
Hit-to-lead
CG-ONC-01
Prostate Cancer
Androgen Suppression
in-silico lead series
bottom of page